iGlarLixi versus Basal Plus Rapid-Acting Insulin in Adults with Type 2 Diabetes Advancing from Basal Insulin Therapy: The SoliSimplify Real-World Study
Rory McCrimmon (Lead / Corresponding author), Alice Y. Y. Cheng, Gagik R. Galstyan, Khier Djaballah, Xuan Li, Mathieu Coudert, Juan P. Frias
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'iGlarLixi versus Basal Plus Rapid-Acting Insulin in Adults with Type 2 Diabetes Advancing from Basal Insulin Therapy: The SoliSimplify Real-World Study'. Together they form a unique fingerprint.